Day: March 18, 2024

TORONTO, March 18, 2024 (GLOBE NEWSWIRE) — Churchill Resources Inc. (“Churchill” or the “Company”) (TSXV: CRI) announces that it has accepted the resignation of non-executive director Ms. Jessie Liu-Ernsting from the Company’s Board of Directors effective today. The Board thanks Ms. Liu-Ernsting for her dedication to the Company and wishes her well in her future endeavours as she pursues other opportunities. About Churchill Resources Inc. Churchill Resources Inc. is a Canadian exploration company focused on high grade, magmatic nickel sulphides in Canada, principally at its prospective Taylor Brook and Florence Lake properties in Newfoundland & Labrador. The Churchill management team, board and its advisors have decades of combined management experience in mineral exploration and in the establishment of successful publicly...

Coherent Executives at Optica Executive ForumThree Coherent executives will be speaking at the Optica Executive Forum held in conjunction with the OFC Conference in San Diego on March 25, 2024.PITTSBURGH, March 18, 2024 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a pioneer in photonic solutions, is proud to announce its participation at the upcoming Optica Executive Forum at OFC 2024, being held at the Hilton San Diego Bayfront on March 25 in conjunction with the OFC conference.Renowned for its history of assembling panels of industry executives and technological innovators, the Optica Executive Forum will feature Coherent Chair and CEO, Dr. Vincent D. (“Chuck”) Mattera, Jr., on the CEO Panel. The event will focus on how the panelists have navigated their organizations through changes, challenges, and opportunities. Additionally,...

– Awards Dr. Berkowitz an Inducement Grant in accordance with Nasdaq Listing Rule 5635(c)(4) – NEW HAVEN, Conn., March 18, 2024 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced the appointment of Noah Berkowitz, M.D., Ph.D., to the role of Chief Medical Officer and a member of the Executive Committee reporting to President and Chief Executive Officer John Houston, Ph.D. Effective today, Dr. Berkowitz will lead the ongoing clinical development of Arvinas’ PROTAC® protein degrader programs in oncology and neuroscience. “We are thrilled to have Dr. Berkowitz join Arvinas as we continue advancing multiple programs with the goal of improving the lives of patients with serious diseases,” said John Houston,...

GEORGETOWN, Cayman Islands, March 18, 2024 (GLOBE NEWSWIRE) — StoneCo Ltd. (Nasdaq: STNE; B3: STOC31) (“Stone” or the “Company”) is announcing a planned transition within the Board of Directors. After a decade of fundamental contributions, our founder, Mr. André Street has chosen not to seek re-election at the upcoming Annual General Meeting (“AGM”), which will occur by the end of April 2024. In similar vein, Mr. Conrado Engel, our Vice Chairman, and Patricia Verderesi Schindler, will also not seek re-election, having completed their two-year commitment to the Company. In preparation for this transition, the proposal is to appoint Mr. Mauricio Luchetti as the new Chairman, and Mr. Gilberto Caldart as the Vice-Chairman of our Board of Directors pursuant to the terms of the Company’s Articles of Association, subject to the...

The long term incentive plan of December 2020 (the “2020 LTIP”) for Hexagon Purus ASA (the “Company”) vested upon approval of the 2023 annual financial statements. Consequently, the Company’s board of directors, has resolved to issue in total 909,742 new shares to the entitled employees pursuant to the authorization to issue shares granted on 25 May 2023. Following registration of the share issue, the Company’s registered share capital will be NOK 27,770,719.80, divided into 277,709,198 shares, each having a face value of NOK 0.10. 541,242 of the new shares were issues to PDMRs, as further specified in the attached forms. For additional information, please contact: Salman Alam, Chief Financial Officer, Hexagon Purus Telephone: +47 476 12 713 | salman.alam@hexagonpurus.comMathias Meidell,  Investor...

SAN FRANCISCO, March 18, 2024 (GLOBE NEWSWIRE) — WalkMe Ltd. (NASDAQ:WKME), a leading provider of digital adoption solutions, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the Securities and Exchange Commission. The annual report on Form 20-F can be accessed on the Company’s investors relations website at https://ir.walkme.com or on the SEC’s website at www.sec.gov. WalkMe will provide a hard copy of the annual report containing its audited financial statements, free of charge, to its shareholders upon request. Requests should be directed in writing by email to investors@walkme.com. About WalkMeWalkMe (WKME) pioneered the world’s leading Digital Adoption Platform (DAP) so companies can effectively navigate the constant change brought on by technology. With WalkMe,...